{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T07:08:43Z","timestamp":1773644923800,"version":"3.50.1"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,10,25]],"date-time":"2018-10-25T00:00:00Z","timestamp":1540425600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,10,25]],"date-time":"2018-10-25T00:00:00Z","timestamp":1540425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U19 AI096111"],"award-info":[{"award-number":["U19 AI096111"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UM1 AI126623"],"award-info":[{"award-number":["UM1 AI126623"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U19 AI051731"],"award-info":[{"award-number":["U19 AI051731"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI116184"],"award-info":[{"award-number":["AI116184"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UM1 AI126617"],"award-info":[{"award-number":["UM1 AI126617"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Allogeneic transplantation (allo-HCT) has led to the cure of HIV in one individual, raising the question of whether transplantation can eradicate the HIV reservoir. To test this, we here present a model of allo-HCT in SHIV-infected, cART-suppressed nonhuman primates. We infect rhesus macaques with SHIV-1157ipd3N4, suppress them with cART, then transplant them using MHC-haploidentical allogeneic donors during continuous cART. Transplant results in ~100% myeloid donor chimerism, and up to 100% T-cell chimerism. Between 9 and 47 days post-transplant, terminal analysis shows that while cell-associated SHIV DNA levels are reduced in the blood and in lymphoid organs post-transplant, the SHIV reservoir persists in multiple organs, including the brain. Sorting of donor-vs.-recipient cells reveals that this reservoir resides in recipient cells. Moreover, tetramer analysis indicates a lack of virus-specific donor immunity post-transplant during continuous cART. These results suggest that early post-transplant, allo-HCT is insufficient for recipient reservoir eradication despite high-level donor chimerism and GVHD.<\/jats:p>","DOI":"10.1038\/s41467-018-06736-7","type":"journal-article","created":{"date-parts":[[2018,10,19]],"date-time":"2018-10-19T09:58:13Z","timestamp":1539943093000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Evidence for persistence of the SHIV reservoir early after MHC haploidentical hematopoietic stem cell transplantation"],"prefix":"10.1038","volume":"9","author":[{"given":"Lucrezia","family":"Colonna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher W.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6707-7051","authenticated-orcid":false,"given":"John B.","family":"Schell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith M.","family":"Carlson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6011-0576","authenticated-orcid":false,"given":"Victor","family":"Tkachev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sowmya","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Willi M.","family":"Obenza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronica","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia S.","family":"Polacino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather","family":"Mack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiu-Lok","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katie","family":"Zeleski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joe","family":"Olvera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott N.","family":"Furlan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0575-6475","authenticated-orcid":false,"given":"Hengqi","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agne","family":"Taraseviciute","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel J.","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kayla","family":"Betz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer F.","family":"Lane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte E.","family":"Hotchkiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cassie","family":"Moats","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Audrey","family":"Baldessari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert D.","family":"Murnane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"English","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cliff A.","family":"Astley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Solomon","family":"Wangari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Agricola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel","family":"Ahrens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoto","family":"Iwayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"May","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurence","family":"Stensland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meei-Li W.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith R.","family":"Jerome","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5949-4947","authenticated-orcid":false,"given":"Hans-Peter","family":"Kiem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leslie S.","family":"Kean","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,10,25]]},"reference":[{"key":"6736_CR1","doi-asserted-by":"publisher","first-page":"15109","DOI":"10.1073\/pnas.96.26.15109","volume":"96","author":"RT Davey Jr.","year":"1999","unstructured":"Davey, R. T. Jr. et al. HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression. Proc. Natl Acad. Sci. USA 96, 15109\u201315114 (1999).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"6736_CR2","volume-title":"Conference on Retroviruses and Opportunistic Infections","author":"DCNKE Colby","year":"2017","unstructured":"Colby, D. Chomont, N. & Kroon, E. et al.\u00a0HIV RNA rebound postinterruption in persons suppressed in Fiebig I acute HIV.\u00a0 In Conference on Retroviruses and Opportunistic Infections (Seattle, WA, USA, 2017)."},{"key":"6736_CR3","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1056\/NEJMoa0802905","volume":"360","author":"G Hutter","year":"2009","unstructured":"Hutter, G. et al. Long-term control of HIV by CCR5 Delta32\/Delta32 stem-cell transplantation. N. Engl. J. Med. 360, 692\u2013698 (2009).","journal-title":"N. Engl. J. Med."},{"key":"6736_CR4","doi-asserted-by":"publisher","first-page":"2791","DOI":"10.1182\/blood-2010-09-309591","volume":"117","author":"K Allers","year":"2011","unstructured":"Allers, K. et al. Evidence for the cure of HIV infection by CCR5Delta32\/Delta32 stem cell transplantation. Blood 117, 2791\u20132799 (2011).","journal-title":"Blood"},{"key":"6736_CR5","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1093\/jnci\/dji072","volume":"97","author":"GM Clifford","year":"2005","unstructured":"Clifford, G. M. et al. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J. Natl Cancer Inst. 97, 425\u2013432 (2005).","journal-title":"J. Natl Cancer Inst."},{"key":"6736_CR6","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1046\/j.1365-2141.2001.02661.x","volume":"112","author":"L Sutton","year":"2001","unstructured":"Sutton, L. et al. Acute myeloid leukaemia in human immunodeficiency virus-infected adults: epidemiology, treatment feasibility and outcome. Br. J. Haematol. 112, 900\u2013908 (2001).","journal-title":"Br. J. Haematol."},{"key":"6736_CR7","first-page":"8502641","volume":"2016","author":"BT Williamson","year":"2016","unstructured":"Williamson, B. T. & Leitch, H. A. Higher risk myelodysplastic syndromes in patients with well-controlled HIV infection: clinical features, treatment, and outcome. Case Rep. Hematol. 2016, 8502641 (2016).","journal-title":"Case Rep. Hematol."},{"key":"6736_CR8","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1182\/blood-2017-04-551606","volume":"130","author":"JC Alvarnas","year":"2017","unstructured":"Alvarnas, J. C., Zaia, J. A. & Forman, S. J. How I treat patients with HIV-related hematological malignancies using hematopoietic cell transplantation. Blood 130, 1976\u20131984 (2017).","journal-title":"Blood"},{"issue":"Suppl","key":"6736_CR9","doi-asserted-by":"publisher","first-page":"S96","DOI":"10.1016\/j.clml.2014.06.020","volume":"14","author":"A Rios","year":"2014","unstructured":"Rios, A. HIV-related hematological malignancies: a concise review. Clin. Lymphoma Myeloma Leuk. 14, S96\u2013S103 (2014).","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"6736_CR10","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1038\/nm1196-1240","volume":"2","author":"Y Huang","year":"1996","unstructured":"Huang, Y. et al. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat. Med. 2, 1240\u20131243 (1996).","journal-title":"Nat. Med."},{"key":"6736_CR11","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/S0092-8674(00)80110-5","volume":"86","author":"R Liu","year":"1996","unstructured":"Liu, R. et al. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86, 367\u2013377 (1996).","journal-title":"Cell"},{"key":"6736_CR12","first-page":"2438","volume":"371","author":"J Verheyen","year":"2014","unstructured":"Verheyen, J., Esser, S. & Kordelas, L. More on shift of HIV tropism in stem-cell transplantation with CCR5 delta32\/delta32 mutation. N. Engl. J. Med. 371, 2438 (2014).","journal-title":"N. Engl. J. Med."},{"key":"6736_CR13","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1056\/NEJMc1405805","volume":"371","author":"L Kordelas","year":"2014","unstructured":"Kordelas, L. et al. Shift of HIV tropism in stem-cell transplantation with CCR5 Delta32 mutation. N. Engl. J. Med. 371, 880\u2013882 (2014).","journal-title":"N. Engl. J. Med."},{"key":"6736_CR14","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1093\/infdis\/jit086","volume":"207","author":"TJ Henrich","year":"2013","unstructured":"Henrich, T. J. et al. Long-term reduction in peripheral blood HIV type 1 reservoirs following reduced-intensity conditioning allogeneic stem cell transplantation. J. Infect. Dis. 207, 1694\u20131702 (2013).","journal-title":"J. Infect. Dis."},{"key":"6736_CR15","doi-asserted-by":"publisher","first-page":"319","DOI":"10.7326\/M14-1027","volume":"161","author":"TJ Henrich","year":"2014","unstructured":"Henrich, T. J. et al. Antiretroviral-free HIV-1 remission and viral rebound after allogeneic stem cell transplantation: report of 2 cases. Ann. Intern. Med. 161, 319\u2013327 (2014).","journal-title":"Ann. Intern. Med."},{"key":"6736_CR16","doi-asserted-by":"publisher","first-page":"e1004406","DOI":"10.1371\/journal.ppat.1004406","volume":"10","author":"M Mavigner","year":"2014","unstructured":"Mavigner, M. et al. Persistence of virus reservoirs in ART-treated SHIV-infected rhesus macaques after autologous hematopoietic stem cell transplant. PLoS Pathog. 10, e1004406 (2014).","journal-title":"PLoS Pathog."},{"key":"6736_CR17","doi-asserted-by":"publisher","first-page":"e91230","DOI":"10.1172\/jci.insight.91230","volume":"2","author":"CW Peterson","year":"2017","unstructured":"Peterson, C. W. et al. Loss of immune homeostasis dictates SHIV rebound after stem-cell transplantation. JCI Insight 2, e91230 (2017).","journal-title":"JCI Insight"},{"key":"6736_CR18","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1182\/blood-2015-08-664706","volume":"128","author":"JC Alvarnas","year":"2016","unstructured":"Alvarnas, J. C. et al. Autologous hematopoietic cell transplantation for HIV-related lymphoma: results of the BMT CTN 0803\/AMC 071 trial. Blood 128, 1050\u20131058 (2016).","journal-title":"Blood"},{"key":"6736_CR19","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1097\/QAI.0b013e31828e6163","volume":"63","author":"AR Cillo","year":"2013","unstructured":"Cillo, A. R. et al. Plasma viremia and cellular HIV-1 DNA persist despite autologous hematopoietic stem cell transplantation for HIV-related lymphoma. J. Acquir. Immune Defic. Syndr. 63, 438\u2013441 (2013).","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"6736_CR20","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1172\/JCI80563","volume":"126","author":"DR Kuritzkes","year":"2016","unstructured":"Kuritzkes, D. R. Hematopoietic stem cell transplantation for HIV cure. J. Clin. Invest. 126, 432\u2013437 (2016).","journal-title":"J. Clin. Invest."},{"key":"6736_CR21","doi-asserted-by":"publisher","first-page":"496","DOI":"10.3389\/fimmu.2017.00496","volume":"8","author":"AM Dickinson","year":"2017","unstructured":"Dickinson, A. M. et al. Graft-versus-leukemia effect following hematopoietic stem cell transplantation for leukemia. Front. Immunol. 8, 496 (2017).","journal-title":"Front. Immunol."},{"key":"6736_CR22","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1097\/QAD.0b013e328340fe28","volume":"25","author":"G Hutter","year":"2011","unstructured":"Hutter, G. & Thiel, E. Allogeneic transplantation of CCR5-deficient progenitor cells in a patient with HIV infection: an update after 3 years and the search for patient no. 2. AIDS 25, 273\u2013274 (2011).","journal-title":"AIDS"},{"key":"6736_CR23","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/jmp.12060","volume":"42","author":"CW Peterson","year":"2013","unstructured":"Peterson, C. W. et al. Robust suppression of env-SHIV viremia in Macaca nemestrina by 3-drug ART is independent of timing of initiation during chronic infection. J. Med. Primatol. 42, 237\u2013246 (2013).","journal-title":"J. Med. Primatol."},{"key":"6736_CR24","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1111\/j.1600-0684.2007.00243.x","volume":"36","author":"P Polacino","year":"2007","unstructured":"Polacino, P. et al. Immunogenicity and protective efficacy of Gag\/Pol\/Env vaccines derived from temporal isolates of SIVmne against cognate virus challenge. J. Med. Primatol. 36, 254\u2013265 (2007).","journal-title":"J. Med. Primatol."},{"key":"6736_CR25","doi-asserted-by":"publisher","first-page":"8729","DOI":"10.1128\/JVI.00558-06","volume":"80","author":"RJ Song","year":"2006","unstructured":"Song, R. J. et al. Molecularly cloned SHIV-1157ipd3N4: a highly replication- competent, mucosally transmissible R5 simian-human immunodeficiency virus encoding HIV clade C Env. J. Virol. 80, 8729\u20138738 (2006).","journal-title":"J. Virol."},{"key":"6736_CR26","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1385\/IR:36:1:51","volume":"36","author":"JD Steckbeck","year":"2006","unstructured":"Steckbeck, J. D. & Cole, K. S. Dissecting the humoral immune response to simian immunodeficiency virus: mechanisms of antibody-mediated virus neutralization. Immunol. Res. 36, 51\u201360 (2006).","journal-title":"Immunol. Res."},{"key":"6736_CR27","doi-asserted-by":"publisher","first-page":"12449","DOI":"10.1128\/JVI.01708-08","volume":"82","author":"GD Tomaras","year":"2008","unstructured":"Tomaras, G. D. et al. Initial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia. J. Virol. 82, 12449\u201312463 (2008).","journal-title":"J. Virol."},{"key":"6736_CR28","doi-asserted-by":"publisher","first-page":"780","DOI":"10.3389\/fimmu.2017.00780","volume":"8","author":"MA French","year":"2017","unstructured":"French, M. A., Tjiam, M. C., Abudulai, L. N. & Fernandez, S. Antiviral functions of human immunodeficiency virus type 1 (HIV-1)-specific IgG antibodies: effects of antiretroviral therapy and implications for therapeutic HIV-1 vaccine design. Front. Immunol. 8, 780 (2017).","journal-title":"Front. Immunol."},{"issue":"408","key":"6736_CR29","doi-asserted-by":"publisher","first-page":"eaan3085","DOI":"10.1126\/scitranslmed.aan3085","volume":"9","author":"Victor Tkachev","year":"2017","unstructured":"Tkachev, V. et al. Combined OX40L and mTOR blockade controls effector T cell activation while preserving Treg reconstitution after transplant. Sci. Transl. Med. 9, pii: eaan3085 (2017).","journal-title":"Science Translational Medicine"},{"key":"6736_CR30","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/s00251-005-0787-1","volume":"57","author":"MC Penedo","year":"2005","unstructured":"Penedo, M. C. et al. Microsatellite typing of the rhesus macaque MHC region. Immunogenetics 57, 198\u2013209 (2005).","journal-title":"Immunogenetics"},{"key":"6736_CR31","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1111\/j.1600-6143.2010.03272.x","volume":"10","author":"CP Larsen","year":"2010","unstructured":"Larsen, C. P. et al. An MHC-defined primate model reveals significant rejection of bone marrow after mixed chimerism induction despite full MHC matching. Am. J. Transplant. 10, 2396\u20132409 (2010).","journal-title":"Am. J. Transplant."},{"key":"6736_CR32","doi-asserted-by":"publisher","first-page":"5403","DOI":"10.1182\/blood-2010-06-289272","volume":"116","author":"WP Miller","year":"2010","unstructured":"Miller, W. P. et al. GVHD after haploidentical transplantation: a novel, MHC-defined rhesus macaque model identifies CD28- CD8\u2009+\u2009T cells as a reservoir of breakthrough T-cell proliferation during costimulation blockade and sirolimus-based immunosuppression. Blood 116, 5403\u20135418 (2010).","journal-title":"Blood"},{"key":"6736_CR33","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1111\/j.1600-6143.2011.03873.x","volume":"12","author":"LS Kean","year":"2012","unstructured":"Kean, L. S., Singh, K., Blazar, B. R. & Larsen, C. P. Nonhuman primate transplant models finally evolve: detailed immunogenetic analysis creates new models and strengthens the old. Am. J. Transplant. 12, 812\u2013819 (2012).","journal-title":"Am. J. Transplant."},{"key":"6736_CR34","doi-asserted-by":"publisher","first-page":"e0179039","DOI":"10.1371\/journal.pone.0179039","volume":"12","author":"N Holman","year":"2017","unstructured":"Holman, N. et al. Isolation of a monoclonal antibody from a phage display library binding the rhesus macaque MHC class I allomorph Mamu-A1*001. PLoS ONE 12, e0179039 (2017).","journal-title":"PLoS One"},{"key":"6736_CR35","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1097\/QAD.0000000000000702","volume":"29","author":"CW Peterson","year":"2015","unstructured":"Peterson, C. W. et al. Lack of viral control and development of combination antiretroviral therapy escape mutations in macaques after bone marrow transplantation. AIDS 29, 1597\u20131606 (2015).","journal-title":"AIDS"},{"key":"6736_CR36","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.virol.2011.11.024","volume":"423","author":"M Horiike","year":"2012","unstructured":"Horiike, M. et al. Lymph nodes harbor viral reservoirs that cause rebound of plasma viremia in SIV-infected macaques upon cessation of combined antiretroviral therapy. Virology 423, 107\u2013118 (2012).","journal-title":"Virology"},{"key":"6736_CR37","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1038\/nm.4411","volume":"23","author":"JD Estes","year":"2017","unstructured":"Estes, J. D. et al. Defining total-body AIDS-virus burden with implications for curative strategies. Nat. Med. 23, 1271\u20131276 (2017).","journal-title":"Nat. Med."},{"key":"6736_CR38","doi-asserted-by":"publisher","first-page":"e87914","DOI":"10.1371\/journal.pone.0087914","volume":"9","author":"JD Deere","year":"2014","unstructured":"Deere, J. D. et al. Analysis of multiply spliced transcripts in lymphoid tissue reservoirs of rhesus macaques infected with RT-SHIV during HAART. PLoS ONE 9, e87914 (2014).","journal-title":"PLoS ONE"},{"key":"6736_CR39","doi-asserted-by":"publisher","first-page":"e1006956","DOI":"10.1371\/journal.ppat.1006956","volume":"14","author":"CW Peterson","year":"2018","unstructured":"Peterson, C. W. et al. Differential impact of transplantation on peripheral and tissue-associated viral reservoirs: Implications for HIV gene therapy. PLoS Pathog. 14, e1006956 (2018).","journal-title":"PLoS Pathog."},{"key":"6736_CR40","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.immuni.2014.08.014","volume":"41","author":"N Calantone","year":"2014","unstructured":"Calantone, N. et al. Tissue myeloid cells in SIV-infected primates acquire viral DNA through phagocytosis of infected T cells. Immunity 41, 493\u2013502 (2014).","journal-title":"Immunity"},{"key":"6736_CR41","doi-asserted-by":"publisher","first-page":"S111","DOI":"10.1093\/infdis\/jiw618","volume":"215","author":"DM Margolis","year":"2017","unstructured":"Margolis, D. M. & Archin, N. M. Proviral latency, persistent human immunodeficiency virus infection, and the development of latency reversing agents. J. Infect. Dis. 215, S111\u2013S118 (2017).","journal-title":"J. Infect. Dis."},{"key":"6736_CR42","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1126\/science.273.5283.1856","volume":"273","author":"M Dean","year":"1996","unstructured":"Dean, M. et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia growth and development study, multicenter AIDS cohort study, multicenter hemophilia cohort study, san francisco city cohort, ALIVE study. Science 273, 1856\u20131862 (1996).","journal-title":"Science"},{"key":"6736_CR43","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/j.1365-2249.2010.04312.x","volume":"163","author":"G Hutter","year":"2011","unstructured":"Hutter, G. & Zaia, J. A. Allogeneic haematopoietic stem cell transplantation in patients with human immunodeficiency virus: the experiences of more than 25 years. Clin. Exp. Immunol. 163, 284\u2013295 (2011).","journal-title":"Clin. Exp. Immunol."},{"key":"6736_CR44","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.1182\/blood-2016-07-726547","volume":"128","author":"SN Furlan","year":"2016","unstructured":"Furlan, S. N. et al. Systems analysis uncovers inflammatory Th\/Tc17-driven modules during acute GVHD in monkey and human T cells. Blood 128, 2568\u20132579 (2016).","journal-title":"Blood"},{"key":"6736_CR45","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/j.1600-6143.2011.03737.x","volume":"12","author":"A Page","year":"2012","unstructured":"Page, A. et al. CD40 blockade combines with CTLA4Ig and sirolimus to produce mixed chimerism in an MHC-defined rhesus macaque transplant model. Am. J. Transplant. 12, 115\u2013125 (2012).","journal-title":"Am. J. Transplant."},{"key":"6736_CR46","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1111\/j.1600-6143.2012.04045.x","volume":"12","author":"SK Ramakrishnan","year":"2012","unstructured":"Ramakrishnan, S. K. et al. Evidence for kidney rejection after combined bone marrow and renal transplantation despite ongoing whole-blood chimerism in rhesus macaques. Am. J. Transplant. 12, 1755\u20131764 (2012).","journal-title":"Am. J. Transplant."},{"key":"6736_CR47","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1111\/ajt.14006","volume":"17","author":"HB Zheng","year":"2017","unstructured":"Zheng, H. B. et al. The Knife\u2019s edge of tolerance: inducing stable multilineage mixed chimerism but with a significant risk of CMV reactivation and disease in Rhesus macaques. Am. J. Transplant. 17, 657\u2013670 (2017).","journal-title":"Am. J. Transplant."},{"key":"6736_CR48","doi-asserted-by":"publisher","first-page":"315ra191","DOI":"10.1126\/scitranslmed.aad3231","volume":"7","author":"SN Furlan","year":"2015","unstructured":"Furlan, S. N. et al. Transcriptome analysis of GVHD reveals aurora kinase A as a targetable pathway for disease prevention. Sci. Transl. Med 7, 315ra191 (2015).","journal-title":"Sci. Transl. Med"},{"key":"6736_CR49","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1182\/blood-2014-01-547612","volume":"123","author":"S Kaliyaperumal","year":"2014","unstructured":"Kaliyaperumal, S. et al. CD8-predominant T-cell CNS infiltration accompanies GVHD in primates and is improved with immunoprophylaxis. Blood 123, 1967\u20131969 (2014).","journal-title":"Blood"},{"key":"6736_CR50","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1097\/COH.0000000000000290","volume":"11","author":"N Kumar","year":"2016","unstructured":"Kumar, N., Chahroudi, A. & Silvestri, G. Animal models to achieve an HIV cure. Curr. Opin. HIV AIDS 11, 432\u2013441 (2016).","journal-title":"Curr. Opin. HIV AIDS"},{"key":"6736_CR51","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.blre.2014.09.009","volume":"29","author":"SO Ciurea","year":"2015","unstructured":"Ciurea, S. O. & Bayraktar, U. D. \u201cNo donor\u201d? Consider a haploidentical transplant. Blood. Rev. 29, 63\u201370 (2015).","journal-title":"Blood. Rev."},{"key":"6736_CR52","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/s41409-017-0015-2","volume":"53","author":"JF Fernandes","year":"2018","unstructured":"Fernandes, J. F. et al. Haploidentical bone marrow transplantation with post transplant cyclophosphamide for patients with X-linked adrenoleukodystrophy: a suitable choice in an urgent situation. Bone Marrow Transplant 53, 392\u2013399 (2018).","journal-title":"Bone Marrow Transplant"},{"key":"6736_CR53","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.bbmt.2016.11.006","volume":"23","author":"C Bonfim","year":"2017","unstructured":"Bonfim, C. et al. Haploidentical bone marrow transplantation with post-transplant cyclophosphamide for children and adolescents with fanconi anemia. Biol. Blood Marrow Transplant. 23, 310\u2013317 (2017).","journal-title":"Biol. Blood Marrow Transplant."},{"key":"6736_CR54","doi-asserted-by":"publisher","first-page":"4285","DOI":"10.1182\/blood-2012-07-438408","volume":"120","author":"J Bolanos-Meade","year":"2012","unstructured":"Bolanos-Meade, J. et al. HLA-haploidentical bone marrow transplantation with posttransplant cyclophosphamide expands the donor pool for patients with sickle cell disease. Blood 120, 4285\u20134291 (2012).","journal-title":"Blood"},{"key":"6736_CR55","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.bbmt.2008.03.005","volume":"14","author":"L Luznik","year":"2008","unstructured":"Luznik, L. et al. HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide. Biol. Blood Marrow Transplant. 14, 641\u2013650 (2008).","journal-title":"Biol. Blood Marrow Transplant."},{"key":"6736_CR56","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1128\/AAC.48.5.1469-1487.2004","volume":"48","author":"KK Van Rompay","year":"2004","unstructured":"Van Rompay, K. K. et al. Biological effects of short-term or prolonged administration of 9-[2-(phosphonomethoxy)propyl]adenine (tenofovir) to newborn and infant rhesus macaques. Antimicrob. Agents Chemother. 48, 1469\u20131487 (2004).","journal-title":"Antimicrob. Agents Chemother."},{"key":"6736_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/1742-6405-8-3","volume":"8","author":"BE Sanders-Beer","year":"2011","unstructured":"Sanders-Beer, B. E. et al. Clinical monitoring and correlates of nephropathy in SIV-infected macaques during high-dose antiretroviral therapy. AIDS Res. Ther. 8, 3 (2011).","journal-title":"AIDS Res. Ther."},{"key":"6736_CR58","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1089\/aid.2015.0130","volume":"32","author":"GQ Del Prete","year":"2016","unstructured":"Del Prete, G. Q. et al. Short communication: comparative evaluation of coformulated injectable combination antiretroviral therapy regimens in simian immunodeficiency virus-infected Rhesus Macaques. AIDS Res. Hum. Retroviruses 32, 163\u2013168 (2016).","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"6736_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01631-z","volume":"8","author":"BJ Burwitz","year":"2017","unstructured":"Burwitz, B. J. et al. Allogeneic stem cell transplantation in fully MHC-matched Mauritian cynomolgus macaques recapitulates diverse human clinical outcomes. Nat. Commun. 8, 1418 (2017).","journal-title":"Nat. Commun."},{"key":"6736_CR60","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/bmt.2008.259","volume":"42","author":"M Tomblyn","year":"2008","unstructured":"Tomblyn, M. & Lazarus, H. M. Donor lymphocyte infusions: the long and winding road: how should it be traveled? Bone Marrow Transplant. 42, 569\u2013579 (2008).","journal-title":"Bone Marrow Transplant."},{"key":"6736_CR61","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s00251-011-0587-8","volume":"64","author":"ZP Johnson","year":"2012","unstructured":"Johnson, Z. P. et al. Immunogenetic Management Software: a new tool for visualization and analysis of complex immunogenetic datasets. Immunogenetics 64, 329\u2013336 (2012).","journal-title":"Immunogenetics"},{"key":"6736_CR62","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1128\/JVI.01841-06","volume":"81","author":"RW Wiseman","year":"2007","unstructured":"Wiseman, R. W. et al. Simian immunodeficiency virus SIVmac239 infection of major histocompatibility complex-identical cynomolgus macaques from Mauritius. J. Virol. 81, 349\u2013361 (2007).","journal-title":"J. Virol."},{"key":"6736_CR63","doi-asserted-by":"publisher","first-page":"e1003174","DOI":"10.1371\/journal.ppat.1003174","volume":"9","author":"S Eriksson","year":"2013","unstructured":"Eriksson, S. et al. Comparative analysis of measures of viral reservoirs in HIV-1 eradication studies. PLoS Pathog. 9, e1003174 (2013).","journal-title":"PLoS Pathog."},{"key":"6736_CR64","doi-asserted-by":"publisher","first-page":"e91214","DOI":"10.1172\/jci.insight.91214","volume":"2","author":"SR DiNapoli","year":"2017","unstructured":"DiNapoli, S. R. et al. Tissue-resident macrophages can contain replication-competent virus in antiretroviral-naive, SIV-infected Asian macaques. JCI Insight 2, e91214 (2017).","journal-title":"JCI Insight"},{"key":"6736_CR65","doi-asserted-by":"publisher","DOI":"10.1186\/1742-4690-6-65","volume":"6","author":"O Ho","year":"2009","unstructured":"Ho, O. et al. Pathogenic infection of Macaca nemestrina with a CCR5-tropic subtype-C simian-human immunodeficiency virus. Retrovirology 6, 65 (2009).","journal-title":"Retrovirology"},{"key":"6736_CR66","doi-asserted-by":"publisher","first-page":"7213","DOI":"10.1073\/pnas.86.18.7213","volume":"86","author":"SL Hu","year":"1989","unstructured":"Hu, S. L. et al. Protection of macaques against simian AIDS by immunization with a recombinant vaccinia virus expressing the envelope glycoproteins of simian type D retrovirus. Proc. Natl Acad. Sci. USA 86, 7213\u20137217 (1989).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"6736_CR67","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1089\/08892220050117014","volume":"16","author":"R Hofmann-Lehmann","year":"2000","unstructured":"Hofmann-Lehmann, R. et al. Sensitive and robust one-tube real-time reverse transcriptase-polymerase chain reaction to quantify SIV RNA load: comparison of one- versus two-enzyme systems. AIDS Res. Hum. Retroviruses 16, 1247\u20131257 (2000).","journal-title":"AIDS Res. Hum. Retroviruses"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-06736-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-06736-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-06736-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T19:39:02Z","timestamp":1671565142000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-06736-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,25]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["6736"],"URL":"https:\/\/doi.org\/10.1038\/s41467-018-06736-7","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,25]]},"assertion":[{"value":"1 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4438"}}